2016
DOI: 10.1016/j.bmc.2016.02.040
|View full text |Cite
|
Sign up to set email alerts
|

Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations

Abstract: Inhibition of group IIA secreted phospholipase A2 (GIIA sPLA2) has been an important objective for medicinal chemists. We have previously shown that inhibitors incorporating the 2-oxoamide functionality may inhibit human and mouse GIIA sPLA2s. Herein, the development of new potent inhibitors by molecular docking calculations using the structure of the known inhibitor 7 as scaffold, are described. Synthesis and biological evaluation of the new compounds revealed that the long chain 2-oxoamide based on (S)-valin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
24
0
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 25 publications
(27 citation statements)
references
References 41 publications
1
24
0
2
Order By: Relevance
“…4) exhibited high potency for inhibition of GIIA sPLA 2 (IC 50 143 nM and 68 nM against human and mouse GIIA sPLA 2 , respectively). The inhibitor was proven ten times more selective for GIIA than GV sPLA 2 and did not exhibit any appreciable inhibition against other human and mouse sPLA 2 enzymes [94]. Additionally, inhibitor 26 ( Fig.…”
Section: Inhibitors Of Secreted Phospholipase Amentioning
confidence: 95%
See 1 more Smart Citation
“…4) exhibited high potency for inhibition of GIIA sPLA 2 (IC 50 143 nM and 68 nM against human and mouse GIIA sPLA 2 , respectively). The inhibitor was proven ten times more selective for GIIA than GV sPLA 2 and did not exhibit any appreciable inhibition against other human and mouse sPLA 2 enzymes [94]. Additionally, inhibitor 26 ( Fig.…”
Section: Inhibitors Of Secreted Phospholipase Amentioning
confidence: 95%
“…Molecular docking calculations and MD simulations with AMBER led to the development of the more potent GIIA sPLA 2 inhibitor GK241 ( Fig. 10) [94,140]. Docking calculations have been also employed to simulate the interaction in GIVA cPLA 2 -2oxoamide inhibitor complexes [141].…”
Section: Computational Studies On Phospholipase a 2 Inhibitorsmentioning
confidence: 99%
“…2-Hydroxy acids 8a and 8b were synthesized as described earlier 33 and the synthesis of 8c is depicted in Scheme 1. The key-intermediate was the cyanohydrin 6 , which was converted to carboxylic acid under hydrolytic conditions.…”
Section: Resultsmentioning
confidence: 99%
“…(Nicholls et al., ) Great efforts have been made to find new inhibitors of GIIA sPLA 2 by researchers. (Beaton et al., ; Boukli et al., ; Burke, Gregor, & Tramposch, ; Chen, Chang, Kim, & Park, ; De Rosa, Giordano et al., , De Rosa, Crispino et al., ; Dillard et al., ; Draheim et al., ; Giannini et al., ; Guerrero et al., ; Hagishita et al., ; Iwama, Segawa, Fujii, Ikeda, & Katsumura, ; Kley, Kiedrowski, Unger, & Massing, ; Lehr, Klimt, & Elfringhoff, ; LeMahieu et al., ; Lucas et al., ; Matsumoto et al., ; Meddad‐Belhabich et al., ; Meng, Liu, Zhai, & Lai, ; Mouchlis et al., ; Oslund et al., ; Oslund, Cermak, Verlinde, & Gelb, ; Dillard et al., ; Sawyer et al., ; Schädlich, Büchler, & Beger, ; Smart, Oslund, Walsh, & Gelb, ; Springer et al., ; Tanaka, Itazaki, & Yoshida, ; Tanaka, Matsutani, Matsumoto, & Yoshida, ; Teshirogi et al., ; Touaibia et al., ; Vasilakaki et al., ; Wei et al., ; Wright, Pinto, Sherk, Green, & Magolda, ; Wu et al., ; Ye et al., ; Zhou et al., ) Respectable compounds showed high inhibitory activity, and there was an inhibitor whose IC 50 reaches 4 nM. (Draheim et al., ; Sawyer et al., ) Some representative inhibitors of GIIA sPLA 2 are shown in Figure .…”
Section: Introductionmentioning
confidence: 99%
“…(Nicholls et al, 2014) Great efforts have been made to find new inhibitors of GIIA sPLA 2 by researchers. (Beaton et al, 1994;Boukli et al, 2008;Burke, Gregor, & Tramposch, 1995;Chen, Chang, Kim, & Park, 2006;De Rosa, Giordano et al, 1998, De Rosa, Crispino et al, 1998Dillard et al, 1996a;Draheim et al, 1996;Giannini et al, 2001;Guerrero et al, 2007;Hagishita et al, 1996;Iwama, Segawa, Fujii, Ikeda, & Katsumura, 1998;Kley, Kiedrowski, Unger, & Massing, 1999;Lehr, Klimt, & Elfringhoff, 2001;LeMahieu et al, 1993;Lucas et al, 2000;Matsumoto et al, 1995;Meddad-Belhabich et al, 2010;Meng, Liu, Zhai, & Lai, 2013;Mouchlis et al, 2011;Oslund, Cermak, Verlinde, & Gelb, 2008;Dillard et al, 1996b;Sawyer et al, 2005;Schädlich, Büchler, & Beger, 1987;Smart, Oslund, Walsh, & Gelb, 2006;Springer et al, 1996;Tanaka, Itazaki, & Yoshida, 1992;Tanaka, Matsutani, Matsumoto, & Yoshida, 1992;Teshirogi et al, 1996;Touaibia et al, 2007;Vasilakaki et al, 2016;Wei et al, 2008;Wright, Pinto, Sherk, Green, & Magolda, 1992;Wu et al, 2011;…”
Section: Introductionmentioning
confidence: 99%